In Vivo Delivery Of Rnai With Lipid-Based Nanoparticles

We have collected information about In Vivo Delivery Of Rnai With Lipid-Based Nanoparticles for you. Follow the links to find out details on In Vivo Delivery Of Rnai With Lipid-Based Nanoparticles.


In Vivo Delivery of RNAi with Lipid-Based Nanoparticles

    https://www.researchgate.net/publication/51190095_In_Vivo_Delivery_of_RNAi_with_Lipid-Based_Nanoparticles
    Proper delivery of siRNAs by lipid-based nanoparticles or encapsulation of siRNA into PEGylated nanoliposomes, both lead to downregulation of P-gp expression in doxorubicin-resistant breast cancer ...

In vivo delivery of RNAi with lipid-based nanoparticles.

    https://www.ncbi.nlm.nih.gov/pubmed/21639780
    Aug 15, 2011 · The major challenge for RNAi-based therapy is the delivery system that meets human therapeutic needs. Therefore, engineering vectors with good delivery efficiency and safety profile is an intense area of research. Lipid-based nanoparticles for RNAi have yielded successful advances in vivo and to an extent in clinical trials.Author: Leaf Huang, Yang Liu

In Vivo Delivery of RNAi with Lipid-Based Nanoparticles ...

    https://www.annualreviews.org/doi/full/10.1146/annurev-bioeng-071910-124709
    The major challenge for RNAi-based therapy is the delivery system that meets human therapeutic needs. Therefore, engineering vectors with good delivery efficiency and safety profile is an intense area of research. Lipid-based nanoparticles for RNAi have yielded successful advances in vivo and to …

Degradable lipid nanoparticles with predictable in vivo ...

    https://www.nature.com/articles/ncomms5277
    Jun 27, 2014 · Figure 3: In vivo siRNA delivery activity of lipidoid nanoparticles. ( a ) Of the ~100 lipidoids tested in mice, 15 induced high levels of Factor VII knockdown at a …Author: Kathryn A. Whitehead, Kathryn A. Whitehead, J Robert Dorkin, Arturo J. Vegas, Philip H. Chang, Omid ...

In vivo endothelial siRNA delivery using polymeric ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207430/
    In vivo endothelial siRNA delivery using polymeric nanoparticles with low ... differs from traditional lipid-based nanoparticle formulations by delivering siRNA to lung endothelial cells without substantially reducing gene expression in pulmonary immune cells, hepatocytes, or peritoneal immune cells, at low doses. ... this is the first ...Author: James E. Dahlman, Carmen Barnes, Omar F. Khan, Aude Thiriot, Siddharth Jhunjunwala, Taylor E. Shaw, ...

Efficient Delivery of Antisense Oligonucleotides Using ...

    https://www.sciencedirect.com/science/article/pii/S2162253120300536
    The efficient delivery of antisense oligonucleotides (ASOs) to the targeted cells and organs remains a challenge, in particular, in vivo.Here, we investigated the ability of a library of biodegradable lipid nanoparticles (LNPs) in delivering ASO to both cultured human cells and animal models.Author: Liu Yang, Feihe Ma, Fang Liu, Jinjin Chen, Xuewei Zhao, Qiaobing Xu

Lipid-Based Nanoparticles in the Systemic Delivery of siRNA

    https://www.medscape.com/viewarticle/818963
    Oct 25, 2019 · This review discusses the hurdles of systemic siRNA delivery and highlights the recent progress made in lipid-based nanoparticles, which are categorized based on their key lipid components ...

In Vivo Delivery of RNAi with Lipid-Based Nanoparticles ...

    https://www.deepdyve.com/lp/annual-reviews/in-vivo-delivery-of-rnai-with-lipid-based-nanoparticles-g221IQMM0z
    Aug 15, 2011 · Read "In Vivo Delivery of RNAi with Lipid-Based Nanoparticles, Annual Review of Biomedical Engineering" on DeepDyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips.

Inside out: optimization of lipid nanoparticle ...

    https://www.nature.com/articles/s41434-019-0095-2
    Jul 12, 2019 · We postulate that the ionization of the lipid caused lower retention of the RNA, which then resulted in lower transfection and in vivo delivery efficiencies, as confirmed by the failure to induce ...Author: Anna K. Blakney, Paul F. McKay, Bárbara Ibarzo Yus, Yoann Aldon, Robin J. Shattock

Lipid-Based Nanosystems for the Delivery of siRNA ...

    https://www.sciencedirect.com/science/article/pii/B9780128133392000165
    Overcoming the challenging pharmacokinetics of siRNAs using different strategies, including lipid-based delivery systems, has required an enormous effort, which has shaped the current landscape of RNAi medicines progressing through clinical development, focusing on the liver as the major target organ.Author: Nuno A. Fonseca, Rui M. Lopes, Ana F. Cruz, Ana C. Gregório, Ângela Valério-Fernandes, Vera Moura, S...

Searching for In Vivo Delivery Of Rnai With Lipid-Based Nanoparticles?

You can just click the links above. The data is collected for you.

Related Delivery Info